PDF

The Only Dedicated Event for Pharma Launch – From Strategy to Execution to Impact

With nearly one‑third of drug launches falling short of expectations and early performance often setting the tone, launch success proved more critical than ever.

That’s why the #PHLEX Summit returned to London this December, bringing together 20+ senior experts from AstraZeneca, Pfizer, Bayer, Takeda, Merck Group, and more.

Across two dynamic conference days and one hands‑on workshop, attendees explored the real‑world challenges and case studies shaping pharma launch in 2025. This year’s agenda was sharper, bolder, and built around the priorities shared by the community.

Explore Pharma Launch Excellence: 2025 vs 2026

Discover how pharmaceutical launch strategies are evolving with our latest comparative analysis. This report highlights key market trends, emerging therapeutic areas, and the factors behind launch failures and successes, giving you actionable insights to plan effectively for 2026. Read the full analysis now

Pharma Launch Readiness Checklist: Your 10-Step Guide to Pharma Launch Success

Is your pharma launch ready? This concise checklist distills the key insights from our 2025 Global State of Pharma Launch Excellence Industry Report into a practical guide for launch leaders, brand teams, and cross-functional stakeholders. Learn how to navigate complexity, avoid common pitfalls, and drive long-term success, from strategy and market entry to post-launch performance. Download your copy now and future-proof your next launch>>